The project uses preclinical seizure models and neuroscience techniques to help develop new antiepileptic agents. Some 800-1000 novel compounds per year are evaluated against conventional drugs for anticonvulsant efficacy and potency, neurotoxicity, effect on liver function, and mechanism of action. Promising compounds, which exhibit a high level and/or unusual spectrum of anticonvulsant activity with superior therapeutic potential, are selected for detailed toxicology studies and subsequent clinical trials in epileptic patients. The project has been continually funded since 1975 and every new anticonvulsant introduced to clinical use in the USA during the past 40 years has been evaluated in this research program.
The program is an integral part of the Department of Pharmacology and Toxicology and, as such, provides a site for research training of undergraduate students, departmental graduate students and postdoctoral fellows. Faculty aligned with the program also provide instruction to professional students in the College of Pharmacy and the School of Medicine.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 30 S 2000 E, Salt Lake City,utah 84112,united States
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://pharmacy.utah.edu/add/
- Keywords
- Epilepsy and neuroscience.
- HQ
- Salt Lake City, Utah
Anticonvulsant Drug Development (Add) Program Questions
Anticonvulsant Drug Development (Add) Program's website is https://pharmacy.utah.edu/add/
Anticonvulsant Drug Development (Add) Program's LinkedIn profile is https://www.linkedin.com/company/add-program-utah
Anticonvulsant Drug Development (Add) Program has
5 employees.
View email and phone details for 5
employees at Anticonvulsant Drug Development (Add) Program.
Anticonvulsant Drug Development (Add) Program's industry is
Research Services
Anticonvulsant Drug Development (Add) Program's top competitors are
Agbt - Advances In Genome Biology And Technology,
Arup Laboratories,
Anilocus, Inc.,
A Little Bird, Llc,
Sierra-At-Tahoe Resort,
Neuralink.
Anticonvulsant Drug Development (Add) Program's categories are Research Services
Anticonvulsant Drug Development (Add) Program's founding year is 1975
